AXA SA Share Price Euronext Paris

Equities

CSNV

FR001400M7B2

Life & Health Insurance

Market Closed - Euronext Paris 15:30:09 24/04/2024 BST 5-day change 1st Jan Change
32.6 EUR -0.91% Intraday chart for AXA SA -.--% -.--%

Financials

Sales 2024 * 107B 115B 9,098B Sales 2025 * 112B 120B 9,511B Capitalization 67.3B 72.17B 5,711B
Net income 2024 * 7.8B 8.36B 662B Net income 2025 * 8.34B 8.95B 708B EV / Sales 2024 * 0.75 x
Net Debt 2024 * 13.4B 14.37B 1,137B Net Debt 2025 * 13.4B 14.37B 1,137B EV / Sales 2025 * 0.72 x
P/E ratio 2024 *
8.79 x
P/E ratio 2025 *
8.06 x
Employees 94,705
Yield 2024 *
7.01%
Yield 2025 *
7.57%
Free-Float 78.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.91%
3 months-0.40%
More quotes
Current year
27.00
Extreme 27
33.02
1 year
27.00
Extreme 27
33.02
3 years
27.00
Extreme 27
33.02
5 years
27.00
Extreme 27
33.02
10 years
27.00
Extreme 27
33.02
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 31/12/11
Director of Finance/CFO - 31/12/99
Chief Operating Officer - 30/11/21
Members of the board TitleAgeSince
Director/Board Member 63 29/06/20
Director/Board Member 53 24/04/18
Director/Board Member 56 28/04/21
More insiders
AXA is the European leading insurance group. Net sales break down by activity as follows: - damage insurance (51.6%): mainly car insurance, home insurance, property damage, civil liability, and major risk insurance. The group also offers assistance services (medical assistance for travelers, breakdown service for vehicles, etc.); - life insurance (46.8%): sale of savings policies, retirement accounts, estate planning services, and health insurance to individuals and companies; - asset management (1.5%): EUR 843 billion of assets managed at the end of 2023; - other (0.1%): mainly banking activities in France, Belgium and Germany.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
30.57 EUR
Average target price
38.25 EUR
Spread / Average Target
+25.12%
Consensus